Learn More Genetic Testing for Monogenic Obesity Genetic Testing for Monogenic Obesity This advanced service is designed for individuals with a BMI over 40 and a history of childhood obesity
Historically, treatment rates for obesity have been alarmingly low, with less than 1% of obese individuals ever receiving anti-obesity medication or surgery
The best time is whichever you will remember and maintain every single week without fail
3 MACE includes cardiovascular death, non-fatal heart attack, and non-fatal stroke
If you undershoot, draw more
The FDA approved semaglutide for chronic weight loss management in adults with a body mass index (BMI) of 30 kg/m2 or higher or those with a BMI of 27 kg/m2 or higher and at least one weight-related ailment, such as high cholesterol, high blood pressure, or type 2 diabetes